Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials Farhad PazanMirko PetrovicMartin Wehling Review Open access 07 August 2020 Pages: 1 - 12
Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials Can ChenKunming PanQianzhou Lv Review 11 August 2020 Pages: 13 - 24
Doctor’s aptitude for switching from innovator etanercept to biosimilar etanercept in inflammatory rheumatic diseases: experience from a single French rheumatology tertiary care center Omar Al TabaaAdrien EtchetoMaxime Dougados Clinical Trial 05 September 2020 Pages: 25 - 33
The impact of acetylsalicylic acid dosed at bedtime on circadian rhythms of blood pressure in the high-risk group of cardiovascular patients—a randomized, controlled trial Beata KrasińskaLech PaluszkiewiczZbigniew Krasiński Pharmacodynamics Open access 21 September 2020 Pages: 35 - 43
Genetic and clinical determinants of mizoribine pharmacokinetics in renal transplant recipients Rui DaiJingjie LiPan Chen Pharmacogenetics 15 August 2020 Pages: 45 - 53
Optimization of infliximab therapy in inflammatory bowel disease using a dashboard approach—an Indian experience Mihika B. DaveAlpa J. DheraiTester F. Ashavaid Pharmacokinetics and Disposition 15 August 2020 Pages: 55 - 62
Tacrolimus monitoring parameters are not associated with acute cellular rejection following lung transplantation Christina C. KaoJustin SegravesAmit D. Parulekar Pharmacokinetics and Disposition 15 August 2020 Pages: 63 - 69
Diltiazem on tacrolimus exposure and dose sparing in Chinese pediatric primary nephrotic syndrome: impact of CYP3A4, CYP3A5, ABCB1, and SLCO1B3 polymorphisms Junyan WangLingfei HuangLuo Fang Pharmacokinetics and Disposition 15 August 2020 Pages: 71 - 77
Prolonged infusion of linezolid is associated with improved pharmacokinetic/pharmacodynamic (PK/PD) profiles in patients with external ventricular drains Wenjun ZhaoLingti KongXiaofei Wu Pharmacokinetics and Disposition 18 August 2020 Pages: 79 - 86
Model-based simulation to support the extended dosing regimens of atezolizumab Chen-Hsi ChouLi-Feng Hsu Pharmacokinetics and Disposition 17 August 2020 Pages: 87 - 93
Estimation of the area under concentration-time curve of polymyxin B based on limited sampling concentrations in Chinese patients with severe pneumonia Wenqian ChenHuifang LiuPengmei Li Pharmacokinetics and Disposition 01 September 2020 Pages: 95 - 105
The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany Thomas GrimmsmannWolfgang Himmel Pharmacoepidemiology and Prescription Open access 17 August 2020 Pages: 107 - 115
The clinical and educational outcomes of an inter-professional student-led medication review team, a pilot study Michael O. ReumermanMilan C. RichirJelle Tichelaar Pharmacoepidemiology and Prescription Open access 08 August 2020 Pages: 117 - 123
A systematic approach for introduction of novel treatments to a chronic patient group: sacubitril-valsartan as a case study Helena NorbergEllinor BergdahlKrister Lindmark Pharmacoepidemiology and Prescription Open access 21 August 2020 Pages: 125 - 131
Risk of sexual dysfunction with progestin-based contraceptives in women of child-bearing age Michael Y. GuoMohit SodhiMahyar Etminan Pharmacoepidemiology and Prescription 15 August 2020 Pages: 133 - 140
Remdesivir-induced symmetrical drug–related intertriginous and flexural exanthema (SDRIFE)? A case report with review of the literature Johannes HeckDirk O. StichtenothBenjamin Krichevsky Letter to the Editor Open access 06 August 2020 Pages: 141 - 144
Allopurinol use and prevention of gout attack Shih-Wei LaiYu-Hung KuoKuan-Fu Liao Letter to the Editor 15 August 2020 Pages: 145 - 145